CONVERGEN was established in 2020 in the beautiful Suzhou Industrial Park. The company is committed to advancing from Industry 1.0 to 2.0, building a global innovative drug scientific transformation platform. Centered on First-in-Class (FIC) drugs, it aims to achieve efficient translation from early-stage science to clinical proof-of-concept, realizing high-impact innovation from 0 to 1. The company focuses on R&D of innovative drugs with independent intellectual property rights and global.

• Prototype Design: Structured layout planning for the platform's core functionalities.

• Visual Design: International, minimalist style aligned with biopharmaceutical industry aesthetics.

• Front-end Production: H5 responsive development ensuring cross-device compatibility.

• System Development: Backend architecture supporting content management and data presentation.

• Maintenance Services: Ongoing technical support and system updates.